Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Podcast

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Magazine & Journal Articles
A Broader Focus for Tomorrow's MMs
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Toolkits/Methodology
Guidance for Writing Comments
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Issue Brief
Alarm Safety Management
This learning lab covers alarm safety management in the health care supply chain field.
Letter/Comment
IRS Issues Final Rule Implementing Medical Device Excise Tax
An announcement of the Final Rule issued by the IRS.
Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Issue Brief
Medical Device Excise Tax - What You Should Know
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.